Who Owns Lumen Metabolism? A Complete Ownership Guide
What this guide covers
- Company Ownership Structure
- Founders and Leadership Team
- Investment and Funding History
- Parent Company Information
- Business Model and Operations
- Future Direction and Growth
Understanding who owns Lumen Metabolism requires looking at the company's structure, founders, and investment backing. This guide provides the facts about the organisation behind this metabolism measurement device.
Company Ownership Structure
Lumen Metabolism is owned and operated by Metaflow Ltd, a private technology company based in Israel. The company was established to develop and commercialise the Lumen device, which measures metabolic state through breath analysis.
Metaflow Ltd maintains full operational control over product development, manufacturing, and distribution of the Lumen device. The company operates as a private enterprise, meaning it is not publicly traded on stock exchanges.
The ownership structure reflects a venture-backed model. Multiple investment rounds have brought external investors into the company. However, the founding team retains significant stakes and operational control.
Key Fact: Company Headquarters
Metaflow Ltd operates from Israel and manages global distribution of Lumen Metabolism products across multiple markets including the UK, USA, Canada, and Australia.
Founders and Leadership Team
Lumen Metabolism was founded by Avi Geiger and Michal Mor. Both founders brought expertise in health technology and metabolic science to the project. Their vision focused on creating accessible tools for personal metabolic measurement.
Avi Geiger serves as Chief Executive Officer. His background includes experience in digital health and consumer technology. Geiger leads the strategic direction and overall business operations of Metaflow Ltd.
Michal Mor contributes as a co-founder with focus on product development and scientific validation. The leadership team expanded over time to include specialists in nutrition science, software engineering, and business operations.
Current Executive Leadership
- CEO and co-founder overseeing overall strategy
- Chief Scientific Officer managing research and validation
- Chief Technology Officer directing product development
- Vice President of Operations handling manufacturing and distribution
- Head of Marketing managing brand and customer acquisition
The executive team brings combined experience from leading health tech companies and research institutions. This expertise informs the development of the breath metabolism device and supporting Lumen app.
Investment and Funding History
Metaflow Ltd has secured substantial funding through multiple investment rounds. These investments have enabled rapid product development and market expansion.
Funding Timeline
- Seed funding round established initial capital for prototype development
- Series A funding accelerated product refinement and clinical research
- Series B funding enabled international expansion and manufacturing scale-up
- Additional rounds supported marketing and distribution infrastructure
Major venture capital firms have invested in the company. These investors recognised the potential of metabolic measurement technology in the health and fitness market.
💰 Investor Profile
Investors include venture capital firms specialising in health technology and consumer wellness. They provide not only capital but also strategic guidance and industry connections.
📈 Growth Impact
Funding has enabled expansion into new markets, development of the metabolism tracker platform, and investment in clinical research validating the device.
Parent Company Information
Metaflow Ltd operates as the parent company for all Lumen Metabolism products and services. The company structure is relatively straightforward with no holding company above it.
The organisation maintains subsidiary operations in key markets. These regional entities handle local distribution, customer support, and regulatory compliance.
Global Operations Structure
Metaflow Ltd coordinates operations across multiple regions. Each market has dedicated teams managing customer relationships and product support.
- European operations based in multiple countries
- North American distribution network
- Asia-Pacific market development teams
- Research and development centres
This decentralised approach allows Lumen Metabolism to serve different markets effectively. Local teams understand regional regulations and customer preferences.
Business Model and Operations
Metaflow Ltd operates on a hybrid revenue model combining device sales with subscription services. Customers purchase the Lumen tracker device and then subscribe to access the full platform features.
Primary Revenue Sources
🛍️ Device Sales
Direct sales of the Lumen device through the company website and authorised retailers generate upfront revenue.
📱 Subscription Revenue
Monthly and annual subscriptions to the Lumen app and premium features provide recurring income.
🤝 Partnership Revenue
Partnerships with fitness platforms and health services create additional revenue opportunities.
The subscription model ensures ongoing customer engagement. Users pay monthly or annually for access to personalised recommendations based on their metabolic data.
Manufacturing and Distribution
Metaflow Ltd partners with contract manufacturers for device production. The company maintains quality control standards throughout the manufacturing process.
Distribution occurs through multiple channels including direct-to-consumer sales, fitness retailers, and health platforms. This multi-channel approach maximises market reach.
Future Direction and Growth
The company continues to invest in research validating the how Lumen metabolism tracker works. Clinical studies support the accuracy and effectiveness of the device.
Metaflow Ltd plans to expand into new markets and develop additional features for the platform. The company aims to become the leading provider of personal metabolic measurement technology.
Current Strategic Priorities
- Expanding market presence in emerging regions
- Developing advanced analytics and AI-powered recommendations
- Building partnerships with healthcare providers
- Conducting additional clinical research
- Enhancing the mobile app experience
Understanding who owns Lumen Metabolism shows a company focused on innovation and customer value. Metaflow Ltd's ownership structure supports rapid development and market responsiveness.
Key Takeaways About Lumen Ownership
- Metaflow Ltd is the parent company owning all Lumen Metabolism products
- Founded by Avi Geiger and Michal Mor with extensive health tech experience
- Backed by venture capital investors specialising in health technology
- Operates as a private company with no public stock trading
- Generates revenue through device sales and subscription services
- Maintains global operations across multiple markets
The ownership and structure of Lumen Metabolism reflects a modern health technology company. Private ownership allows for focused product development and long-term strategic planning. The company's commitment to research and innovation continues to drive improvements to the portable metabolism tracker platform.
For customers, understanding the company behind Lumen Metabolism provides confidence in the product's future development and support. Metaflow Ltd's investment in research and technology ensures continuous improvement of the metabolic measurement experience.